A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Single nucleotide polymorphisms (SNPs) in genes encoding nutrient transporters, metabolizing enzymes, and sensing receptors alter nutrient requirements and responses. Examples: MTHFR variants affect folate metabolism and homocysteine; APOE4 carriers have higher cholesterol responses to dietary fat; aldosterone synthase variants influence sodium sensitivity. Nutrient-gene interactions can explain variable responses to supplementation and dietary interventions. While personalized nutrition based on genomics is promising, most SNPs have small effect sizes, and gene expression and environment often outweigh genetic variation.
Analyze SNP databases for common polymorphisms in nutrient genes; predict phenotypic outcomes (e.g., lactase persistence, caffeine metabolism) from genotype.
You already know that the genetic code is written in DNA and that single nucleotide polymorphisms (SNPs) are single-letter changes in that sequence that vary between individuals. Nutrigenomics asks: when those letter changes fall in genes that handle nutrients — transporters, metabolizing enzymes, receptors — do they change how the body processes food? The answer is yes, but with important caveats about scale.
Consider folate metabolism as the clearest example. The enzyme MTHFR converts dietary folate into the active form used for DNA methylation and homocysteine clearance. A common SNP (C677T) reduces MTHFR enzyme activity by roughly 30–70% depending on whether you carry one or two copies of the variant allele. People with the low-activity variant tend to accumulate homocysteine and may need more dietary folate or a pre-methylated supplement form to achieve the same metabolic outcome as someone with the standard variant. This is gene-nutrient interaction in its simplest form: the same diet produces different biochemical outcomes in different genotypes.
APOE genotype offers a more complex case. APOE4 carriers — roughly 25% of the population — show larger increases in LDL cholesterol in response to dietary saturated fat compared to APOE3 carriers. The mechanism involves how the APOE4 protein interacts with LDL receptors and influences cholesterol clearance. For an APOE4 carrier, a high-saturated-fat diet poses meaningfully greater cardiovascular risk than the same diet poses for an APOE3 carrier. But notice what this does not mean: it does not mean APOE4 carriers must eat differently in every dimension, only that this specific exposure (saturated fat → LDL elevation) operates differently in their biology.
The practical limit of nutrigenomics is effect size. Most individual SNPs shift nutrient requirements by small amounts — often less than the variation explained by gut microbiome composition, cooking methods, meal timing, or physical activity. The MTHFR and APOE examples are among the largest and best-replicated; the vast majority of gene-nutrient associations discovered in genome-wide studies are modest and inconsistent across populations. This is why the Common Misconceptions section warns against treating a single SNP test as a dietary prescription. Gene expression also matters: the same SNP can have different functional impact depending on which other genes are active, and diet itself changes gene expression through epigenetic mechanisms — so the causal arrow runs in both directions. Nutrigenomics is a genuine field with genuine findings, but its clinical translation requires treating genetic variants as one input among many rather than as deterministic nutritional fate.
No topics depend on this one yet.